Suppr超能文献

β受体密度降低可解释体位性低血压中吲哚洛尔和普瑞特罗耐受性的产生。

Decrease in beta-receptor density explaining the development of pindolol- and prenalterol-tolerance in orthostatic hypotension.

作者信息

Andersen E B, Lindskov H O, Marving J, Boesen F, Beck-Nielsen H, Hesse B

出版信息

Dan Med Bull. 1985 Jun;32(3):194-6.

PMID:2861975
Abstract

A 58-year-old woman with diabetic autonomic dysfunction was well treated for orthostatic hypotension with pindolol. After eight months however, symptoms recurred in spite of continued treatment with pindolol. Addition of prenalterol, a beta-blocking agent with very high intrinsic sympathomimetic activity, had a marked clinical effect on her orthostatic hypotension. Before treatment with prenalterol, stroke volume and left ventricular enddiastolic volume markedly decreased during tilt, as demonstrated by radionuclide angiography. After short-term prenalterol treatment, the orthostatic decreases of stroke volume and left ventricular end-diastolic volume were less pronounced. During continued prenalterol treatment, both symptoms and haemodynamic changes recurred in the erect position. Beta-receptor density in her lymphocytes decreased from elevated levels before prenalterol to subnormal levels, when the clinical effect had disappeared. The data suggest that the tolerance development to prenalterol may be explained by the decrease in beta-adrenergic receptor density.

摘要

一名患有糖尿病自主神经功能障碍的58岁女性,使用吲哚洛尔对体位性低血压进行了有效治疗。然而八个月后,尽管继续使用吲哚洛尔治疗,症状仍复发。添加具有非常高内在拟交感活性的β受体阻滞剂普瑞特罗,对她的体位性低血压有显著临床效果。在用普瑞特罗治疗前,放射性核素血管造影显示,倾斜期间每搏量和左心室舒张末期容积明显减少。短期普瑞特罗治疗后,体位性每搏量和左心室舒张末期容积的减少不那么明显。在继续使用普瑞特罗治疗期间,直立位时症状和血流动力学变化再次出现。当临床效果消失时,她淋巴细胞中的β受体密度从普瑞特罗治疗前的升高水平降至正常以下水平。数据表明,对普瑞特罗耐受性的产生可能是由于β肾上腺素能受体密度降低所致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验